METiS Pharmaceuticals Inc is the world’s first AI-driven drug formulation company. Through the integration of machine learning, quantum simulation, and high-throughput experimentation, we enable formulation scientists to rapidly, comprehensively, and intelligently develop novel drug candidates.
Metis is founded by an enthusiastic team of MIT researchers and serial entrepreneurs. Our cross-disciplinary expertise and deep industry experiences allow Metis to innovate drug formulation and quickly bring differentiable drug products from benchtop to market.
TechnologiesAI Companies (Drug Discovery) Quantum Theory in Drug Discovery
METiS Pharmaceuticals is a venture-backed, preclinical biotech company. Our team of MIT researchers and serial entrepreneurs built the world's first AI-driven formulation platform to enable targeted, smart novel drug candidates. Through the integration of machine learning, quantum simulation, and high-throughput experimentation, we enable formulation scientists to rapidly, comprehensively and intelligently develop clinically differentiable products. These disruptive ways of working fundamentally transform drug development, and drug product lifecycle management, and ultimately bring more quality drug products to patients.
Our breakthrough formulation platform technology enables us to develop targeted, smart novel drug candidates, and deliver risk-mitigated, faster-to-market drug products. We collaborate with XtalPi Inc, a leading computation-driven biotech company, to develop new formulation drug products to address unmet clinical needs.
No services posted yet